GS1 India organised a conference - ‘Harmonisation of 2D barcodes on Pharmaceutical Drugs’ at the India Habitat Center, New Delhi, on January 12th, 2023. The objective was to provide guidance to the pharmaceutical manufacturers and help them comply with the regulation related to barcoding issued by the Ministry of Health and Family Welfare. The conference was attended by 150+ delegates from the top 300 brands who needed to comply with the guidelines.
Corporate Chief
Principal Scientist
Scientist
Scientist
Drug Controller General of India
Co-founder
CEO & Co-founder
Secretary General
The conference highlighted how harmonisation of product codes is critical to uniquely identify the pharmaceutical drug and achieve visibility in the supply chain. Discussions asserted that industry needs to look at the implementation of notification beyond the regulatory requirement and see how it can benefit all stakeholders like hospitals, pharmacies, and chemists. Various discussions revealed that pharma companies lacked visibility beyond the stockist in the supply chain, and the data required for collaboration with multiple stakeholders was stored in silos. It was concluded that the use of standardised and harmonised barcodes on drugs is essential to achieve supply chain visibility and have end-to-end visibility.
Topics
